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Abstract
Background: Many complementary therapies offer benefits for patients with cancer. Others may be risky for
patients due to negative interactions with conventional treatment and adverse effects. Therefore, cancer patients
need guidance from health care providers to assess complementary modalities appropriately to receive benefits
and avoid harm.
Method: In a self-administered questionnaire-based cross-sectional study, we compared knowledge and attitudes of
health care providers with no training in complementary modalities to that of health care providers with training in
complementary modalities about the risks for patients who combine complementary modalities with conventional
treatment in cancer care. The analysis was based on responses from 466 participants.
Results: The attitudes and knowledge about direct risk followed provider specialty. Ninety-four percent of the medical
doctors, 93% of the nurses, and 87% of the providers with dual training, but 70% of the complementary therapists, believed
that complementary modalities can cause adverse effects (p< 0.001). The majority of the medical doctors and nurses
believed that it is risky to combine complementary and conventional cancer treatments (78% and 93%, respectively),
compared to 58% of the providers with dual training and 43% of the complementary therapists (p< 0.001). Eighty-nine
percent of the medical doctors and nurses believed that complementary modalities should be subjected to more scientific
testing before being accepted by conventional health care providers, in contrast to 56% of the dually trained and 57% of
the complementary therapists (p < 0.001). The majority of the medical doctors (61%) and nurses (55%) would have neither
discouraged nor encouraged the use of complementary modalities if patients asked them for advice. Moreover, less than
1% of the complementary therapists would have discouraged the use of conventional cancer treatments. The study
participants believed that the most important factor to recommend a complementary cancer modality to patients is
evidence for safety.
Conclusion: The health care providers in this study believed that complementary modalities are associated with direct risk
and can cause adverse effects, and that it is risky to combine conventional and complementary treatments due to potential
harmful interactions.
Keywords: Direct risk, Indirect risk, Risk assessment, Patient safety, Conventional health care providers, Complementary
therapists, Complementary and alternative medicine: Cancer car
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Background
Use of complementary therapies is common among
cancer patients both in Norway [1] and worldwide [2, 3].
Complementary therapies are integrated in the care of
cancer patients in many countries. In Norway, these mo-
dalities are used alongside conventional cancer treat-
ments, mostly practiced outside the conventional health
care system and by lay therapists and as complementary
to conventional cancer care, rather than as an alternative
[4]. The most commonly used complementary modal-
ities in Norway are massage, acupuncture, naprapathy,
reflexology, osteopathy, cupping and spiritual healing
[5]. Of these therapies, spiritual healing is the comple-
mentary therapy most commonly used by cancer
patients [6].
Cancer patients often use complementary modalities
to relieve pain, and to lessen symptoms of nausea and
vomiting associated with chemotherapy or surgical
anesthesia, in addition to reduce adverse effects of
chemotherapy [2]. One example is using acupuncture to
help reduce some adverse effects of cancer treatment
[7]. Evidence from randomized controlled trials supports
the use of complementary modalities such as acupunc-
ture, massage, music therapy, and relaxation techniques
[2, 8]. However, dietary supplements, herbs, and other
botanicals can be problematic because of their potential
adverse effects or negative interactions with chemother-
apy, radiotherapy, or surgery, but may be beneficial
when patients do not undergo these treatments [9].
Due to the frequent use of complementary modalities,
cancer patients should receive guidance from qualified
health care providers about the advantages and disad-
vantages of complementary modalities in an open,
evidence-based, and patient-centered manner [2, 8].
They should be informed about potential benefits, risks,
and realistic expectations when combining complemen-
tary modalities with conventional treatment in cancer
care [10, 11]. However, risks associated with different
complementary modalities have been poorly investi-
gated, often due to the assumption that many comple-
mentary modalities are “natural” and, therefore,
associated with low or no risks.
Risk associated with any health care intervention is
generally separated into direct and indirect risk [12].
Direct risk describes the risk associated with an inter-
vention such as harm caused by medical treatments,
procedures and pharmacological products. Indirect risk
describes a threat to patient safety that is, in the broader
sense, associated with the whole treatment setting and
clinical practice. Indirect risk may include a provider
with limited medical skills who may overlook serious
symptoms and thereby cause a delay of necessary con-
ventional treatment [13, 14], or insufficient or inappro-
priate communication between patients and health care
providers with or without complementary training.
Another example is continued care in conventional or
complementary settings of unproven effectiveness or not
conforming to the patients’ values or preferences, while
delaying more appropriate complementary modality or
conventional care with positive evidence of effectiveness.
One strategy for safely guiding patients in health care
decision-making is to examine the risk/benefit ratio;
benefits of a health care modality have to clearly
outweigh potential risks for providers to consider
recommending it to patients. The stronger the evidence
for efficacy and safety, the stronger the argument that
the modality should be recommended [2]. On the other
hand, when the evidence for safety and efficacy is weak,
it is sensible to discourage the patients from using the
modality. The evidence of safety and efficacy for many
complementary modalities is mixed and weak [2, 8], and
studies shows that medical doctors find it difficult to
recommend many complementary modalities due to a
lack of scientific evidence on effect [15–17].
Several complementary therapies offer potential
benefits for patients with cancer. Others seem to be
ineffective and may present risk for adverse effects or
negative interactions. Therefore, it is important for
health care providers to guide cancer patients to
assess complementary modalities appropriately to
receive benefit while avoiding harm.
We investigate what knowledge and attitudes Norwegian
health care providers (medical doctors [oncologists and
family physicians], nurses, providers with dual training, and
complementary therapists [acupuncturists, reflexologists,
and massage therapists]) have to guide cancer patients
about risks associated with complementary modalities in
general when combined with conventional cancer treat-
ment. The aim of this paper is to:
– Compare knowledge and attitudes of health care
providers with no training in complementary
modalities to that of health care providers with
training in complementary modalities about the
risks for patients who combine complementary
modalities with conventional treatment in cancer
care. We consider both direct and indirect risk.
Method
The main study was conducted from March to June
2016. The study protocol was reviewed and the Regional
Committees for Medical and Health Research Ethics
(REC) decided that the study did not need REC approval
(2012/1318/REK Nord).
Participants
The study inclusion criteria were being a currently prac-
ticing oncology doctor, oncology nurse, family physician,
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or complementary therapist (acupuncturist, massage
therapist, reflexologist/zone-therapist). Participants had
to have current or previous clinical experience with
cancer patients. All participants were members of a
professional association. A total of 1341 participants re-
ceived an email or a letter with the questionnaire and
were asked to participate in the survey. A total of 534
(response rate 40%) completed and returned the ques-
tionnaire. We included data from 89 participants from
the vanguard study (response rate 24%) [18]. Seventeen
participants were excluded because they were duplicates
(n = 11) or did not indicate a profession (n = 6). A total
of 140 were non-completers who returned question-
naires that were substantially incomplete; they were ex-
cluded from this analysis. The final sample for this
analysis included 27 oncologists (18% response rate), 89
nurses (62% response rate) 117 family physicians (25%
response rate) and 223 complementary therapists (23%
response rate). As several of the participants reported
more than one profession, the participants were merged
into four mutually exclusive categories: Medical doctors
(n = 142), nurses (n = 69), providers with dual training
(n = 32), and complementary therapists (n = 223) (Fig. 1).
Data collection
This was a self-administered questionnaire-based cross-
sectional study.
Questionnaire content
The questionnaire was based on information re-
trieved from a literature review [17]. The final
version included 86 questions in 8 categories (inclu-
sion, communication with patients, risk in clinical
practice, perception about complementary and con-
ventional treatment modalities, information gathering
about complementary and conventional modalities,
personal demographics, and clinical practice or
hospital work). Data for this analysis were based on
16 questions about risk in clinical practice presented
below.
Data collection procedures
Data collection was based on Dillman survey proce-
dures [19]. Through an e-mail, the participants were
invited to participate in the study and informed that
a new e-mail with a link to the online survey would
be sent a week later. One week after the e-mail with
the link, a second e-mail was sent as a reminder to
the ones who not had responded and as a thank you
to the responders. Finally, after an additional week, a
reminder repeating the link to the survey was sent to
the non-responders. Following the same procedure,
the physicians received the questionnaire by post, but
with the option to complete the questionnaire by ei-
ther post or email.
Fig. 1 Flow chart of the inclusion process in this study
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Measures
Professional, personal and clinical practice characteristics
Participants’ professions were reported in the categories
medical doctor (oncologists and family physicians not
trained and not providing a complementary modality),
nurse (oncology nurses not trained and not providing a
complementary modality), provider with dual training (a
physician or nurse who also provided a complementary
modality, or a complementary therapist with conven-
tional training (e.g., physiotherapist), and complemen-
tary therapist (including acupuncturists, massage
therapists, or reflexologist/zone therapist with no con-
ventional training) (Table 1). Other personal characteris-
tics included age (years), sex (female, male), and level of
education (compulsory, middle level, university up to
4 years, university more than 4 years/PhD). Clinical
practice characteristics included number of patients and
cancer patient visits each week (1–19 patients, 20–39
patients, 40 or more patients), working full time or part
time, and the practice/hospital location (rural area, small
city or large city).
Direct risk
Five dichotomous measures assess attitudes and know-
ledge about direct risks of complementary modalities
used in cancer treatment: (1) complementary modalities
can cause adverse effects; (2) complementary modalities
can cause harmful interactions with conventional treat-
ments; (3) treated patients for whom a complementary
modality was effective; (4) treated patients for whom a
complementary modality was harmful; and (5) combin-
ing complementary and conventional treatments
increases patient risk.
Since many complementary modalities are practiced
outside the established health care service in Norway,
we assumed that the knowledge about these modalities
was limited among the conventional health care
providers. We wanted, therefore,to ask the participants
how familiar they were with several complementary
modalities, including the following: acupuncture,
homeopathy, hands on healing such as Reiki, Tai chi and
qigong, aromatherapy, yoga, mindfulness, zone-therapy/
reflexology, Chinese herbal medicine, other herbal
medicine, chiropractic, osteopathy, and massage. The re-
sponse options for each of these modalities were: none,
little, some, quite a bit and a great deal. In the analysis,
these response options were collapsed into “good know-
ledge” about complementary therapies. A document that
explained and defined the different modalities was at-
tached for the participants to use if they were unfamiliar
with a specific treatment modality and to ensure that
the modalities where understood in the same manner by
the participants. The risk question was asked regarding
complementary modalities in general and not limited to
a specified single therapy (Table 1).
Indirect risk
Sixteen measures assess several dimensions of attitudes
and knowledge toward indirect risks of complementary
modalities used in cancer treatment. (1) Whether
complementary modalities should be subjected to more
scientific testing is a dichotomous measure. (2) Most
important factor for recommending a complementary
modality has the values: evidence for safety, evidence for
efficacy, evidence does not matter, and double response.
(3) Sufficient efficacy evidence to recommend a
Table 1 Good knowledge of complementary therapies
Total (n = 466) Medical Doctor
(n = 142)
Nurse (n = 69) Provider with dual training (n = 32) Complementary therapist (n = 223)
n % n % n % n % n %
Acupuncture 233 50.5 27 19 17 25 26 81.3 163 74.4
Homeopathy 73 16.3 18 12.8 1 1.5 2 6.9 52 24.3
Healing 86 18.9 12 8.6 9 13.4 8 26.7 57 26.3
Thai Chi and Chi gong 86 18.8 5 3.5 3 4.4 11 36.7 67 30.7
Aromatherapy 73 15.9 3 2.1 9 13.2 4 13.8 57 25.9
Yoga 136 29.6 27 19 19 28.4 12 40 78 35.3
Mindfullness 163 35.8 41 29.1 22 33.3 13 43.3 87 39.9
Reflexology 101 22 2 1.4 3 4.5 4 12.9 92 41.8
Chinese herbal medicine 36 7.9 2 1.4 1 1.5 6 20.7 27 12.3
Herbal medicine other than
Chineese
26 5.8 3 2.2 0 0 1 3.4 22 10.2
Naprapathy 56 12.3 10 7.1 3 4.4 3 10.3 40 18.3
Osteopathy 58 12.7 11 7.9 2 2.9 4 13.3 41 18.7
Massage 219 48.1 34 24.5 19 28.8 19 59.4 147 67.4
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complementary modality has the values: no or weak evi-
dence, moderate evidence, strong evidence, and would
not recommend. (4) Sufficient evidence for safety has
the values: no or weak evidence, moderate evidence,
strong evidence, and would not recommend.
(5) Number of complementary modality care patients
who delayed or declined conventional treatment had the
values: none, and one or more. Six dichotomous
measures assess how the provider would address a com-
plementary modality patient who delayed or declined
conventional treatment: (6) have not experienced; (7)
respect patient’s choice; (8) try to convince patient; (9)
encourage patient soliciting a second opinion; (10) ask
family members to intervene; and (11) inform patient of
consequences of not receiving conventional treatment.
(12) Approve of patient combining complementary
and conventional treatments has the values: never,
sometimes, often, and always. (13) Asking patients if
they consider risks of combining complementary and
conventional treatments has the values: never, some-
times, and often/always. (14) Advice given to patients
who ask about complementary modalities has the values:
discourage use, encourage use, neither discourage nor
encourage, and other. (15) Advice given to patients who
ask about conventional treatment has the values:
discourage use, encourage use, neither discourage nor
encourage, and other. (16) Complementary modalities
are dangerous because they delay conventional treat-
ments is dichotomous.
Statistical analysis
Descriptive statistics (counts, percentages) were calcu-
lated, both for those in each profession and among the
four provider groups. Comparisons of provider and prac-
tice characteristics across provider types were analyzed.
Differences in categorical variables were analyzed using
Pearson chi square test or Fisher’s exact test. Analyses of
variance were conducted for continuous variables. The
significance level was defined as p < 0.05 without
adjustment for multiple comparisons. The analysis was
conducted using SPSSV.24.0 for Windows.
Results
Demographics
The professions reported in the study, included oncolo-
gists (n = 27), family physicians (n = 118), oncology
nurses (n = 89), acupuncturists (n = 150), massage thera-
pists (n = 82), and reflexologists/zone-therapists (n = 35)
(Table 1, left column). They were grouped into medical
doctor (n = 142, 30.5%), nurse (n = 69, 14.8%), provider
with dual training (n = 32, 6.9%) and complementary
therapist (n = 223, 47.6%) (Table 1, first row).
Medical doctors were significantly younger than the
other groups (p < 0.001). The groups also differed
significantly in education, with medical doctors having
the highest proportion with more than 4 years of univer-
sity training (p < 0.001).
Most medical doctors and nurses worked full time
(90% and 78%, respectively), compared with complemen-
tary therapists (58%) (p < 0.001). Medical doctors and
providers with dual training reported more patient visits
per week (p < 0.001). The groups differed in practice
locations (p = 0.005), with the largest proportion of
medical doctors (42%) located in rural areas. The largest
proportion of nurses (48%), providers with dual training
(48%) and complementary therapists (39%) worked in
small towns (Table 1).
Direct risk
Overall, the attitudes and knowledge about direct risk
situations followed the provider profession. Responses
were frequently distributed in two opposite ends of the
scales. The majority (82%) of the participants agreed that
complementary modalities could cause adverse effects.
However, discrepancy was found between the different
provider groups, as 94% of the medical doctors, 93% of
the nurses, and 87% of the providers with dual training,
but only 70% of the complementary therapists held this
opinion (p < 0.001). The contrast was striking between
conventional providers and complementary therapists
about whether complementary modalities could cause
harmful interactions with conventional cancer treat-
ments. Seventy-seven percent of the medical doctors
and 85% of the nurses held this opinion, compared to
only 52% of the dually trained and 41% of the comple-
mentary therapists (p < 0.001). Similarly, only 24% of the
medical doctors and 49% of the nurses had had cancer
patients whose treatment with a complementary modal-
ity was effective, in contrast to 96% of the providers with
dual training and 86% of the complementary therapists
(p < 0.001) (Table 2).
Thirty-eight percent of the medical doctors and 52%
of the nurses reported they had ever had cancer patients
whose treatment with a complementary modality was
harmful, compared to only 12% of the providers with
dual training and 9% of the complementary therapies.
However, the majority of the participants (75%)
responded that they had had none or did not know of
patients whose treatment with a complementary moda-
lity was harmful. That is, 62% of the medical doctors,
48% of the nurses, 89% of the dually trained and 91% of
the complementary providers (p < 0.001). The majority
of the medical doctors and nurses believed that it is risky
to combine complementary and conventional cancer
treatments (78% and 93%, respectively), compared to
58% of the providers with dual training and 43% of the
complementary therapists (Table 2).
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Table 2 Characteristics of the participants (n = 466)b
Total (n = 466) Medical doctor (n = 142) Nurse
(n = 69)
Providers with dual




n % n % n % n % n %
Gender < 0.001*
Male 108 27.5 69 51.5 3 12.5 36 19.3
Female 285 72.5 65 48.5 48 100 21 87.5 151 80.7
Missing 73 8 21 8 36
Age. years < 0.001**
Mean age 373 48.7 127 45.4 45 51.2 24 52.2 177 50.1
Missing 93 15 24 8 46
Education < 0.001^
Compulsory 2 0.5 2 1.1
Middle level 33 8.4 33 17.6
University up to 4 years 112 28.4 23 46.9 11 44 78 41.7
University more than
4 years/PhD
248 62.8 134 100 26 53.1 14 56 74 39.6
Missing 71 8 20 7 36
Profession*
Oncology doctor 27 5.8 27 100
Family physician 118 25.3 116 99.1 2 a 1.8
Oncology nurse 89 19.1 69 77.5 20 22.5
Acupuncturist 150 32.2 25 16.7 125 83.3
Massage therapist 82 17.6 6 7.3 76 92.7
Reflexologist/zonetherapist 35 7.5 1 2.9 34 97.1
Clinical practice < 0.001^
Full time health provider 287 72.1 121 89.6 38 77.6 18 72 110 58.2
Part time health provider 92 23.1 11 8.1 10 20.4 5 20 66 34.9
Other (students or retired
persons)
19 4.8 3 2.2 1 2 2 8 13 6.9
Missing 68 7 20 7 34
Patient visits per week < 0.001*
1-19 patients 131 33.8 10 7.6 27 57.4 4 16 90 48.6
20–39 patients 121 31.2 28 21.4 17 36.2 5 20 71 38.4
40 or more patients 136 35.1 93 71 3 6.4 16 64 24 13
Missing 78 11 22 7 38
Cancer patient visits per week < 0.001^
1–19 cancer patients 361 92.1 125 92.6 31 64.6 23 92 182 98.9
20 and more patients 31 7.9 10 7.4 17 35.4 2 8 2 1.1
Missing 74 7 21 7 39
Location 0.005*
Rural area 118 29.7 56 41.5 7 14.6 3 12 52 27.5
Small city. Village
(up to 50.000 inhabitants)
153 38.5 44 32.6 23 47.9 12 48 74 39.2
Large city (> 50.000
inhabitants)
126 31.7 35 25.9 18 37.5 10 40 63 33.3
Missing 69 7 21 7 34
*Pearson’s chi-square test; **One way anova test; ^Fisher’s exact test; bDue to multiple response on one or more variables, the analyzed numbers do
not always add up to the total number; aThese adds to > 32 because providers have more than one area of training
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Indirect risk
Eighty-nine percent of the medical doctors and nurses
believed that complementary modalities should be sub-
jected to more scientific testing before being accepted by
conventional health care providers, in contrast to 56% of
the dually trained and 57% of the complementary thera-
pists (p < 0.001). Overall, the participants believed that
evidence for safety was more important than evidence
for efficacy to recommend a complementary modality to
cancer patients (49% and 40%, respectively). However, a
significant difference was found among the provider
groups. Thirty-eight percent of the medical doctors and
44% of the providers with dual training believed that
evidence for safety was the most important, compared to
60% of the nurses, and 54% of the complementary thera-
pists. Less than half of the medical doctors, nurses and
complementary therapists believed that evidence for effi-
cacy was the most important to recommend a comple-
mentary modality, in contrast to 52% of the dually
trained (p < 0.001). Four percent of the medical doctors
and 9% of the complementary therapists believed that
evidence did not matter (< 0.001) (Table 3).
The contrast was striking between conventional health
care providers and complementary therapists in what
constitutes enough evidence on efficacy to recommend a
complementary modality to cancer patients. The pro-
viders with dual training and complementary therapists
believed that moderate evidence for efficacy was enough
(63% and 44%, respectively), while only 27% of the
medical doctors and 18% of the nurses held this opinion.
On the other hand, 49% of the medical doctors and 64%
of the nurses believed that only strong evidence for
efficacy was enough, compared to 26% of the providers
with dual training and 29% of the complementary thera-
pists. Eighteen percent of the medical doctors, 13% of
the nurses and 14% of the complementary therapists
would never recommend a complementary modality
because of efficacy concerns, 4% of the providers with
dual training agreed (p < 0.001) (Table 3).
Overall, 74% of the participants believed that strong
evidence for safety was the most important to recom-
mend a complementary modality to cancer patients.
Eighty percent of the medical doctors and 84% of the
nurses held this belief, in contrast to 67% of the pro-
viders with dual training and complementary therapists.
Less than 15% of the medical doctors and nurses would
never recommend complementary therapy because of
safety concerns, compared to 4% of the providers with
dual training and 7% of the complementary therapists
(p < 0.001).
Almost all of the providers with dual training and
complementary therapists had no patients who delayed
or declined conventional cancer treatment during the
past year (96% and 94%, respectively), compared to 70%
of the medical doctors and 49% of the nurses.
Conversely, 30% of the medical doctors and 51% of the
nurses had one or more patients who delayed or de-
clined conventional cancer treatment during the past
year, in contrast to 4% of the dually trained and 6% of
the complementary therapists (p < 0.001).
Between group differences were found regarding how
to handle cancer patients who choose to decline or delay
conventional cancer treatment. Most of the medical doc-
tors (63%), nurses (78%) and providers with dual training









therapist (n = 223)
p-value
n % n % n % n % n %
Complementary modalities can cause adverse effects^^ < 0.001*
Yes 376 82.1 134 94.4 64 92.8 27 87.1 151 69.9
Complementary modalities can cause harmful
interactions with conventional treatments
< 0.001*
Yes 265 59.2 105 76.6 55 84.6 16 51.6 89 41.4
Treated patiens for whom a complementary
modality was effective
< 0.001*
Yes 239 60.8 32 24.2 27 49.1 25 96.2 155 86.1
Treated patients for whom a complementary
modality was harmful
< 0.001*
Yes 97 24.7 51 38.3 27 51.9 3 11.5 16 8.8
Combining complementary and conventional
treatments increases patient risk
< 0.001*
Yes 240 62.8 101 77.7 49 92.5 14 58.3 76 43.4
*Pearson’s chi-square test; ^Fisher’s exact test; aDue to multiple and missing responses, the analyzed numbers do not always add up to the total number;^^The
missing response variated between (n = 8 and n = 84)
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(61%) had experienced this, compared to 41% of the
complementary therapists (p < 0.001). Forty percent of
the medical doctors and 51% of the nurses would respect
patient’s choice, in contrast to 36% of the providers with
dual training, and 25% of the complementary therapists
(p < 0.001). Moreover, 46% of the medical doctors would
try to convince patient to consider conventional treat-
ment, compared to 19% of the nurses, 23% of the pro-
viders with dual training, and 19% of the complementary
therapists. Fewer between-group differences were found
in encouraging the patient soliciting a second opinion,
where less than 40% of each groups would have encou-
raged patients to do so (p = 0.122). Less than 5% of
medical doctors and nurses would ask family members to
intervene; however, none of the providers with dual train-
ing or complementary therapists would do so (p = 0.003).
More than 60% of the medical doctors and nurses would
have informed the patient of consequences of not
receiving conventional treatment, in contrast to 32% of
the providers with dual training and 28% of the comple-
mentary therapists (< 0.001) (Table 3).
Fewer between-group differences were found regard-
ing approval of cancer patients´ use of complementary
therapy combined with conventional treatment. Less
than 10% of each provider group would never approve
such use. However, 63% of the medical doctors and 60%
of the nurses would sometimes approve such use, com-
pared to 24% of the providers with dual training and
15% of the complementary therapists. About than 35%
of the providers with dual training and complementary
therapists would often approve such use, compared to
the medical doctors and nurses (20% and 17%, respec-
tively). Eight percent of the medical doctors and 17% of
the nurses would always approve the use of complemen-
tary therapy, in contrast to 44% of the providers with
dual training and 46% of the complementary therapists
(p < 0.001).
Less than half of the medical doctors, nurses, providers
with dual training and complementary therapists reported
that they had never asked their patients if they considered
the risk of combining complementary with conventional
treatment. Between 44% and 55% of medical doctors,
nurses and providers with dual training answered that
they sometimes asked about this. This was in contrast to
the complementary therapists that often/always asked pa-
tients about perceived risk of combining complementary
and conventional treatment (33%) (p < 0.001).
A significant difference was found between the
provider groups regarding what advice to give to cancer
patients if they asked about complementary therapy.
Eight percent of the medical doctors and 4% of the
nurses would discourage the use of complementary mo-
dalities, compared to none of the dually trained and 1%
of the complementary therapists. Two percent of the
medical doctors and 7% of the nurses would encourage
the use, in contrast to 42% of the dually trained and 47%
of the complementary therapists. The majority of the
medical doctors (61%) and nurses (55%) would have
done neither, compared to providers with dual training
(39%) and complementary therapists (32%) (Table 3).
Less than 1% of each provider group would have dis-
couraged the use of conventional medicine if patients
asked for advice. The majority of the participants (78%)
would have encouraged the use of conventional cancer
treatment. However, a significant difference was found
among provider groups. Eighty-seven percent of the
medical doctors, 78% of the nurses and 84% of the
dually trained encouraged such use, in contrast to 71%
of the complementary therapists (p = 0.005).
Seventy-eight percent of the medical doctors and
71% of the nurses believed complementary therapy
could be dangerous because it may delay conventional
treatment, compared to 24% of the providers with
dual training and 22% of the complementary thera-
pists (p < 0.001) (Table 3), (Table 4).
Discussion
Generally, the attitudes and knowledge about comple-
mentary therapies in cancer care followed provider
specialty. The conventional and complementary pro-
viders were mostly in favor of their own discipline.
The majority of the health care providers in this
study believed that complementary modalities could
cause adverse effects and harmful interactions with
conventional cancer treatment. This is in line with
Hyodo et al. [20] who investigated the attitudes of
Japanese clinical oncologists towards complementary
cancer modalities (herbs and over the counter prod-
ucts); a total of 84% of the oncologists considered the
possibility of drug interactions between anticancer
drugs and these products. As regards harmful interac-
tions, more than half of the complementary therapists
in our study did not support this view.
Two-thirds of the medical doctors and more than
three-quarters of the nurses believed that it could be
risky for patients to combine complementary and
conventional cancer treatments. In addition, they
believed that using complementary modalities could be
risky because it might delay conventional treatment. The
complementary therapists believed that to a lesser ex-
tent. However, the assumption that risk associated with
many complementary modalities is indirect is in accor-
dance with Fisher [13], Dantas [21], and Stub [17]. They
found that the main risks associated with homeopathy
and other complementary modalities were indirect; that
is, related to the therapists and clinical practice rather
than the medicine.
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training (n = 32)
Complementary
therapist (n = 223)
p-value
n % n % n % n % n %
Whether complementary modalities should be subjected
to more scientific testing^^
Yes 302 71.6 119 88.8 54 88.5 15 55.6 114 57 < 0.001*
Most important factor for recommending a
complementary modality
< 0.001^
Evidence for safety 209 49.1 52 38.2 37 59.7 12 44.4 108 53.7
Evidence for efficacy 169 39.7 55 40.4 25 40.3 14 51.9 75 37.3
Evidence does not matter 22 5.2 5 3.7 0 0 0 0 17 8.5
Double responses 26 6.1 24 17.6 0 0 1 3.7 1 0.5
Sufficient efficacy evidence to recommend
a complementary modality
< 0.001^
No or weak evidence for efficacy 39 9.3 9 6.6 3 4.9 2 7.4 25 12.9
Moderate evidence for efficacy 151 36.1 37 27.2 11 18 17 63 86 44.3
Strong evidence for efficacy 168 40.2 66 48.5 39 63.9 7 25.9 56 28.9
Would never recommend 60 14.4 24 17.6 8 13.1 1 3.7 27 13.9
Sufficient evidece for safety < 0.001^
No or weak evidence for safety 12 2.9 3 2.2 0 0 1 3.7 8 4.1
Moderate evidence for safety 57 13.6 4 3 3 4.8 7 25.9 43 22.1
Strong evidence for safety 309 73.7 108 80 52 83.9 18 66.7 131 67.2
Would never recommend 41 9.8 20 14.8 7 11.3 1 3.7 13 6.7
Number of complementary modality care patients
who delayed or declined conventional treatment
< 0.001*
No patients 337 80 95 70.4 30 49.2 25 96.2 187 94
One or more patients 84 20 40 29.6 31 50.8 1 3.8 12 6
How the providers would address a complementary
modality patient who delayed or declined
conventional treatment
Have not experienced 206 44.2 52 36.6 15 21.7 12 38.7 127 58.8 < 0.001*
Respect the patient’s choice 157 33.7 57 40.1 35 50.7 11 35.5 54 25.0 < 0.001*
Try to convince patient 127 27.3 65 45.8 13 18.8 7 22.6 42 19.4 < 0.001*
Encourage patient soliciting a second opinion 150 32.2 34 23.9 24 34.8 12 38.7 80 37.0 0.122*
Ask family members to intervene 9 1.9 7 4.9 2 2.9 0 0.0 0 0.0 0.003^
Inform patient of consequences of not receiving
conventional treatment
203 43.6 91 64.1 42 60.9 10 32.3 60 27.8 < 0.001*
Approve of patient combining complementary and
conventional treatments
< 0.001^
Never 23 5.9 12 9 3 5.8 0 0 8 4.5
Sometimes 147 37.8 84 63.2 31 59.6 6 24 26 14.5
Often 107 27.5 27 20.3 9 17.3 8 32 63 35.2
Always 112 28.8 10 7.5 9 17.3 11 44 82 45.8
Asking patients if they consider risks of combining
complementary and conventional treatments
< 0.001*
Never 153 39.2 54 40.3 17 30.4 11 44 71 40.6
Sometimes 147 37.7 59 44 31 55.4 11 44 46 26.3
Often/always 90 23.1 21 15.7 8 14.3 3 12 58 33.1
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Moreover, the conventional health care providers
claimed that complementary modalities should be sub-
jected to more scientific testing, and that evidence for
safety was equally important as evidence for efficacy. To
recommend a complementary modality, they believed
that strong evidence for safety was most important. This
is in line with Fønnebø et al. [22]. His research group
recommended a new strategy for assessing complemen-
tary therapies because many of these modalities have no
regulatory or financial gatekeepers controlling their
therapeutic tools/agents prior to marketing. Consequen-
tially, many modalities are in widespread use before re-
searchers know of their existence and prior to any
consideration about safety issues. The group proposed a
five-phased research strategy, where safety status should
be assessed before the assessment of efficacy.
If patients asked them for advice, the majority (78%) of
the participants in the study and 71% of the complemen-
tary therapists would encourage the use of conventional
cancer treatment. Only two complementary therapists
(1%) would discourage the use of conventional medicine.
These results are in contrast to Cassileth [23] who con-
ducted a survey among patients and complementary
therapists in the USA, and found that 22% of comple-
mentary therapists were supportive of cancer patient’s
use of conventional care, 36% were neutral and 21%
disparaged conventional medicine. However, research
has revealed that the reasons for cancer patient to de-
cline or delay conventional treatment may be due to the
medical doctors’ communication style. In a qualitative
study, Salamonsen [24] investigated a possible relation-
ship between cancer patients’ communication experi-
ences with doctors and the decision to use
complementary modalities as either a supplement or al-
ternative to conventional treatment. She found three
doctor communication styles that influenced the pa-
tients’ treatment decisions: (i) negative communication
experiences because of the use of complementary mo-
dalities; (ii) negative communication experiences re-
sulted in the decision to use complementary modalities,
and in some cases to decline conventional treatment;
and (iii) positive communication experiences that led to
the decision to use complementary modalities as a sup-
plement, and not as an alternative to conventional
treatment.
Cancer patients who decline or delay conventional
cancer treatment should, according to two-thirds of
the medical doctors, be informed about the conse-
quences of not applying conventional treatment. More
than half of the nurses strongly believed in respecting
the patient’s autonomy; they believed this to a greater
degree than did complementary therapists. This is the
opposite of what one would expect, but might be
explained by the nurses’ strong tradition of being the
patients’ advocates [15]. Moreover, more than half of
the medical doctors and nurses neither discouraged
nor encouraged the use of complementary modalities.
Advice may depend on the situation, the medical
doctor’s knowledge of the complementary therapy and
cancer type [17].






training (n = 32)
Complementary
therapist (n = 223)
p-value
n % n % n % n % n %
Advice given to patients who ask about
complementary modalities
< 0.001^
Discourage use 14 3.6 10 7.5 2 3.6 0 0 2 1.1
Encourage use 100 25.8 3 2.3 4 7.3 11 42.3 82 47.1
Neither 177 45.6 81 60.9 30 54.5 10 38.5 56 32.2
Other 97 25 39 29.3 19 34.5 5 19.2 34 19.5
Advice given to patients who ask about
conventional treatment
Discourage use 2 0.5 0 0 0 0 0 0 2 1.1 0.005^
Encourage use 308 78.2 116 86.6 42 77.8 21 84 129 71.3
Neither discourage nor encourage 46 11.7 5 3.7 6 11.1 4 16 31 17.1
Other 38 9.6 13 9.7 6 11.1 0 0 19 10.5
Complementary modalities are dangerous because
they delay conventional treatments
< 0.001*
Yes 178 47.6 100 78.1 35 71.4 6 24 37 21.5
*Pearson’s chi-square test; ^Fisher’s exact test; aDue to multiple and missing responses, the analyzed numbers do not always add up to the total number;^^The
missing response variated between (n = 8 and n = 84)
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Practical implementation
Many complementary therapies offer potential benefits
for patients with cancer. Others seem to be ineffective
and may present risks of adverse effects or interactions.
Therefore, it is important for health care providers to
guide cancer patients to assess complementary moda-
lities appropriately to receive benefit while avoiding
harm. In the training of doctors and nurses, a greater
awareness of potential positive and negative outcomes of
combining conventional and complementary treatment
should be emphasized. More research that investigates
direct and indirect risks of combining these treatment
modalities in cancer care is warranted.
Limitations
The main limitation of this study is the rather low response
rate among the physicians and the complementary thera-
pists. With a 25% response rate or lower in these groups,
the findings are only the expression of a highly selected
group of physicians and complementary therapists. We
might therefore conservatively conclude that the findings of
this study are valid for 18–25% of the physicians and com-
plementary therapists, as the non-respondents may differ
significantly from those who responded [25]. We presume
that physicians with interest in complementary therapies
might be over-represented, as interest in the topic studied
has shown to increase the response rate [26]. However, our
findings are similar to those reported by Hyodo and Frenkel
[20, 27]. This suggests that non-response bias poses a lim-
ited threat to our study’s validity [28]. When it comes to
nurses, however, the findings are more generalizable as the
response rate was much higher, 62%. The high number of
nurses (n = 20) who had additional education as a comple-
mentary therapist indicates, however, that also among
nurses, therapists with an interest for complementary
therapies might be over-represented.
Conclusion
The health care providers in this study believed that com-
plementary modalities used in cancer care are associated
with direct risk and can cause adverse effects, mostly due
to harmful interactions. However, the majority of the
complementary therapists in this study encourage their
patients to apply conventional cancer treatment. The most
important factor to recommend a complementary cancer
modality to patients was found to be evidence for safety.
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